In-Vitro Colorectal Cancer Screening Tests Industry Research Report 2025

Summary


In-Vitro colorectal cancer screening tests use various methods to determine whther a petient has colorectal cancer.

According to APO Research, The global In-Vitro Colorectal Cancer Screening Tests market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for In-Vitro Colorectal Cancer Screening Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for In-Vitro Colorectal Cancer Screening Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for In-Vitro Colorectal Cancer Screening Tests is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of In-Vitro Colorectal Cancer Screening Tests include Alere(Abbott), Beckman Coulter, Siemens Healthcare, Eiken Chemical, Hitachi Chemical (Kyowa Medex), Clinical Genomics Pty Ltd (Quest Diagnostics), Sysmex, QIAGEN and R-Biopharm and etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for In-Vitro Colorectal Cancer Screening Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding In-Vitro Colorectal Cancer Screening Tests.
The In-Vitro Colorectal Cancer Screening Tests market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global In-Vitro Colorectal Cancer Screening Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.

In-Vitro Colorectal Cancer Screening Tests Segment by Company

Alere(Abbott)
Beckman Coulter
Siemens Healthcare
Eiken Chemical
Hitachi Chemical (Kyowa Medex)
Clinical Genomics Pty Ltd (Quest Diagnostics)
Sysmex
QIAGEN
R-Biopharm
Immunostics
In-Vitro Colorectal Cancer Screening Tests Segment by Type

Biomarker Tests
Fecal Occult Blood Tests
CRC DNA Screening Tests
In-Vitro Colorectal Cancer Screening Tests Segment by Application

Hospital and Clinics
Ambulatory
Home Care
In-Vitro Colorectal Cancer Screening Tests Segment by Application

Hospital and Clinics
Ambulatory
Home Care
In-Vitro Colorectal Cancer Screening Tests Segment by Region

North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global In-Vitro Colorectal Cancer Screening Tests market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of In-Vitro Colorectal Cancer Screening Tests and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of In-Vitro Colorectal Cancer Screening Tests.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of In-Vitro Colorectal Cancer Screening Tests companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 In-Vitro Colorectal Cancer Screening Tests by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031)
2.2.2 Biomarker Tests
2.2.3 Fecal Occult Blood Tests
2.2.4 CRC DNA Screening Tests
2.3 In-Vitro Colorectal Cancer Screening Tests by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031)
2.3.2 Hospital and Clinics
2.3.3 Ambulatory
2.3.4 Home Care
2.4 Assumptions and Limitations
3 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Type
3.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Type (2020-2025)
3.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Type (2026-2031)
4 In-Vitro Colorectal Cancer Screening Tests Breakdown Data by Application
4.1 Global In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Application (2020-2025)
4.2 Global In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Application (2026-2031)
5 Global Growth Trends
5.1 Global In-Vitro Colorectal Cancer Screening Tests Market Perspective (2020-2031)
5.2 Global In-Vitro Colorectal Cancer Screening Tests Growth Trends by Region
5.2.1 Global In-Vitro Colorectal Cancer Screening Tests Market Size by Region: 2020 VS 2024 VS 2031
5.2.2 In-Vitro Colorectal Cancer Screening Tests Historic Market Size by Region (2020-2025)
5.2.3 In-Vitro Colorectal Cancer Screening Tests Forecasted Market Size by Region (2026-2031)
5.3 In-Vitro Colorectal Cancer Screening Tests Market Dynamics
5.3.1 In-Vitro Colorectal Cancer Screening Tests Industry Trends
5.3.2 In-Vitro Colorectal Cancer Screening Tests Market Drivers
5.3.3 In-Vitro Colorectal Cancer Screening Tests Market Challenges
5.3.4 In-Vitro Colorectal Cancer Screening Tests Market Restraints
6 Market Competitive Landscape by Players
6.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue
6.1.1 Global Top In-Vitro Colorectal Cancer Screening Tests Players by Revenue (2020-2025)
6.1.2 Global In-Vitro Colorectal Cancer Screening Tests Revenue Market Share by Players (2020-2025)
6.2 Global In-Vitro Colorectal Cancer Screening Tests Industry Players Ranking, 2023 VS 2024 VS 2025
6.3 Global Key Players of In-Vitro Colorectal Cancer Screening Tests Head Office and Area Served
6.4 Global In-Vitro Colorectal Cancer Screening Tests Players, Product Type & Application
6.5 Global In-Vitro Colorectal Cancer Screening Tests Manufacturers Established Date
6.6 Global In-Vitro Colorectal Cancer Screening Tests Market CR5 and HHI
6.7 Global Players Mergers & Acquisition
7 North America
7.1 North America In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031)
7.2 North America In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2020-2025)
7.4 North America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2026-2031)
7.5 United States
7.5 United States
7.6 Canada
7.7 Mexico
8 Europe
8.1 Europe In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031)
8.2 Europe In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
8.3 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2020-2025)
8.4 Europe In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2026-2031)
8.5 Germany
8.6 France
8.7 U.K.
8.8 Italy
8.9 Spain
8.10 Russia
8.11 Netherlands
8.12 Nordic Countries
9 Asia-Pacific
9.1 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031)
9.2 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2020-2025)
9.4 Asia-Pacific In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2026-2031)
9.5 China
9.6 Japan
9.7 South Korea
9.8 India
9.9 Australia
9.10 China Taiwan
9.11 Southeast Asia
10 South America
10.1 South America In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031)
10.2 South America In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2020-2025)
10.4 South America In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2026-2031)
10.5 Brazil
10.6 Argentina
10.7 Chile
10.8 Colombia
10.9 Peru
11 Middle East & Africa
11.1 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size (2020-2031)
11.2 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031
11.3 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2020-2025)
11.4 Middle East & Africa In-Vitro Colorectal Cancer Screening Tests Market Size by Country (2026-2031)
11.5 Saudi Arabia
11.6 Israel
11.7 United Arab Emirates
11.8 Turkey
11.9 Iran
11.10 Egypt
12 Players Profiled
12.1 Alere(Abbott)
12.1.1 Alere(Abbott) Company Information
12.1.2 Alere(Abbott) Business Overview
12.1.3 Alere(Abbott) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.1.4 Alere(Abbott) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.1.5 Alere(Abbott) Recent Developments
12.2 Beckman Coulter
12.2.1 Beckman Coulter Company Information
12.2.2 Beckman Coulter Business Overview
12.2.3 Beckman Coulter Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.2.4 Beckman Coulter In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.2.5 Beckman Coulter Recent Developments
12.3 Siemens Healthcare
12.3.1 Siemens Healthcare Company Information
12.3.2 Siemens Healthcare Business Overview
12.3.3 Siemens Healthcare Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.3.4 Siemens Healthcare In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.3.5 Siemens Healthcare Recent Developments
12.4 Eiken Chemical
12.4.1 Eiken Chemical Company Information
12.4.2 Eiken Chemical Business Overview
12.4.3 Eiken Chemical Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.4.4 Eiken Chemical In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.4.5 Eiken Chemical Recent Developments
12.5 Hitachi Chemical (Kyowa Medex)
12.5.1 Hitachi Chemical (Kyowa Medex) Company Information
12.5.2 Hitachi Chemical (Kyowa Medex) Business Overview
12.5.3 Hitachi Chemical (Kyowa Medex) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.5.4 Hitachi Chemical (Kyowa Medex) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.5.5 Hitachi Chemical (Kyowa Medex) Recent Developments
12.6 Clinical Genomics Pty Ltd (Quest Diagnostics)
12.6.1 Clinical Genomics Pty Ltd (Quest Diagnostics) Company Information
12.6.2 Clinical Genomics Pty Ltd (Quest Diagnostics) Business Overview
12.6.3 Clinical Genomics Pty Ltd (Quest Diagnostics) Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.6.4 Clinical Genomics Pty Ltd (Quest Diagnostics) In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.6.5 Clinical Genomics Pty Ltd (Quest Diagnostics) Recent Developments
12.7 Sysmex
12.7.1 Sysmex Company Information
12.7.2 Sysmex Business Overview
12.7.3 Sysmex Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.7.4 Sysmex In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.7.5 Sysmex Recent Developments
12.8 QIAGEN
12.8.1 QIAGEN Company Information
12.8.2 QIAGEN Business Overview
12.8.3 QIAGEN Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.8.4 QIAGEN In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.8.5 QIAGEN Recent Developments
12.9 R-Biopharm
12.9.1 R-Biopharm Company Information
12.9.2 R-Biopharm Business Overview
12.9.3 R-Biopharm Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.9.4 R-Biopharm In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.9.5 R-Biopharm Recent Developments
12.10 Immunostics
12.10.1 Immunostics Company Information
12.10.2 Immunostics Business Overview
12.10.3 Immunostics Revenue in In-Vitro Colorectal Cancer Screening Tests Business (2020-2025)
12.10.4 Immunostics In-Vitro Colorectal Cancer Screening Tests Product Portfolio
12.10.5 Immunostics Recent Developments
13 Report Conclusion
14 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings